NASDAQ:MDAS

(MDAS) (MDAS) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
$31.35
$31.35
50-Day Range
N/A
52-Week Range
$17.00
$31.35
Volume
N/A
Average Volume
1.79 million shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
MDAS stock logo

About (MDAS) Stock (NASDAQ:MDAS)

MedAssets, Inc. (MedAssets) provides technology-enabled products and services to healthcare organizations, including hospitals, health systems, non-acute healthcare providers, payers, other service providers and product manufacturers. The Company operates its business through two business segments: Spend and Clinical Resource Management (SCM) and Revenue Cycle Management (RCM). The SCM segment delivers market insight, performance improvement advisory and cost management capabilities to healthcare providers. The RCM segment provides revenue cycle management solutions to healthcare providers, primarily hospitals and health systems. The Company’s technology-enabled solutions are delivered through the Company-hosted software or software as a service (SaaS) or Web-based applications. Its Web-based applications employ cloud computing by using the Internet to deploy the Company’s solutions across decentralized health care organizations, providing standardization and compliance.

MDAS Stock News Headlines

“The Biggest Bubble of All Time” – Here’s What to Do.
Despite AI's incredible run-up in 2023, we're getting some conflicting messages. Analysts at JP Morgan warn that an "AI-driven bubble" could drag the entire stock market down. Folks at Morgan Stanley say AI hysteria is creating conditions like the dot-com collapse. Even AI leaders (the people who benefit the most!) are getting worried.
FG Recovers N57Bn Debt from 10 MDAs
“The Biggest Bubble of All Time” – Here’s What to Do.
Despite AI's incredible run-up in 2023, we're getting some conflicting messages. Analysts at JP Morgan warn that an "AI-driven bubble" could drag the entire stock market down. Folks at Morgan Stanley say AI hysteria is creating conditions like the dot-com collapse. Even AI leaders (the people who benefit the most!) are getting worried.
NCDMB, SON most efficient MDAs — FG
Ocean Power Technology Loses Ground on News
See More Headlines
Receive MDAS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for (MDAS) and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
7/29/2015
Today
4/25/2024

Industry, Sector and Symbol

Sector
N/A
Industry
N/A
Sub-Industry
Health Care Technology
Current Symbol
NASDAQ:MDAS
CUSIP
58404510
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
These 7 Stocks Will Be Magnificent in 2024 Cover

With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.

Get This Free Report

MDAS Stock Analysis - Frequently Asked Questions

How were (MDAS)'s earnings last quarter?

(MDAS) (NASDAQ:MDAS) posted its quarterly earnings results on Wednesday, July, 29th. The technology company reported $0.31 earnings per share for the quarter, topping analysts' consensus estimates of $0.27 by $0.04. The technology company had revenue of $190.40 million for the quarter, compared to analyst estimates of $187.45 million. The business's revenue was up 8.6% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.30 earnings per share.

What other stocks do shareholders of (MDAS) own?

Based on aggregate information from My MarketBeat watchlists, some companies that other (MDAS) investors own include CVS Health (CVS), Home Depot (HD), StoneMor (STON), Blackstone (BX), NVIDIA (NVDA), AbbVie (ABBV), Broadcom (AVGO), Cadence Design Systems (CDNS), DexCom (DXCM) and The Goldman Sachs Group (GS).

This page (NASDAQ:MDAS) was last updated on 4/25/2024 by MarketBeat.com Staff

From Our Partners